In the EPO group, there were no cases (0.0%) of ventriculomegaly, while the No EPO group exhibited a 3.8% incidence (5 out of 130 neonates), resulting in a statistically significant difference with a p-value of 0.029. This evidence concerns the gene EPO and Ventriculomegaly.